AR and Familial prostate cancer: A potential difficulty of comparing androgen signaling across prostate cancer cells is - depending on the line - the AR is mutated, alternatively spliced, and expressed at different levels, all of which could affect the transcriptional output measured in response to androgen [44, 45].